Back to News
Market Impact: 0.22
IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
Source: GlobeNewswire
Healthcare & BiotechTechnology & InnovationProduct Launches
IBA will offer its QUANTM irradiation-system solid-target technology to cyclotron users globally, enabling expanded local production of radiometals used in theranostics. The rollout could support broader availability of diagnostic and therapeutic isotopes, but the article provides no financial targets, contract values, or expected revenue impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
IBAB0.72
More News
- Nvidia Faces Questions Over China AI Chip Smuggling Cases
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- Markets slip on dollar pressure, but this IT stock is up 10% today
- One of our most recent defensive buys cleared a hurdle and its stock jumped
- AI’s biggest players promise to police themselves at the White House
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can Hedge Funds Use ChatGPT? A Control Framework
- Palantir (PLTR) Q4 2025 Earnings: 70% Revenue Growth, Then an 11% Single-Day Crash